Gyon Technologies Capital Management, LP Edwards Lifesciences Corp Transaction History

Gyon Technologies Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $267,784 - $348,799	3,251 New	3,251 $269,000
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $235,221 - $296,080	-2,307 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $24,571 - $30,187	-231 Reduced 9.1%	2,307 $299,000
Q3 2021 Nov 18, 2021	BUY	$102.91 - $122.75 $261,185 - $311,539	2,538 New	2,538 $287,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.